{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:51:14Z","timestamp":1787068274972,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chemie-Wirtschaftsf\u00f6rderungsgesellschaft mbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00204-025-04077-1","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:17:37Z","timestamp":1747732657000},"page":"3309-3314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Human metabolism and excretion kinetics of Bronopol after oral administration"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5999-1333","authenticated-orcid":false,"given":"Isabell","family":"Sch\u00f6nrath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0913-3558","authenticated-orcid":false,"given":"Christoph","family":"Schmidtkunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-1274","authenticated-orcid":false,"given":"Katharina E.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"K\u00fcpper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9560-5464","authenticated-orcid":false,"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8328-2837","authenticated-orcid":false,"given":"Holger M.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-8759","authenticated-orcid":false,"given":"Gabriele","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"5","key":"4077_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/cod.14178","volume":"87","author":"M Bizjak","year":"2022","unstructured":"Bizjak M, Adamic K, Bajrovic N et al (2022) Patch testing with the European baseline series and 10 added allergens: Single-centre study of 748 patients. Contact Dermatitis 87(5):439\u2013446. https:\/\/doi.org\/10.1111\/cod.14178","journal-title":"Contact Dermatitis"},{"key":"4077_CR2","first-page":"3","volume":"29","author":"DM Bryce","year":"1978","unstructured":"Bryce DM, Croshaw B, Hall JE, Holland VR, Lessel B (1978) The activity and safety of the antimicrobial agent Bronopol (2-bromo-2-nitropropan-1,3-diol). J Soc Cosmet Chem 29:3\u201324","journal-title":"J Soc Cosmet Chem"},{"issue":"2","key":"4077_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0378-4274(80)90175-7","volume":"6","author":"HS Buttar","year":"1980","unstructured":"Buttar HS, Downie RH (1980) The biotransformation and disposition of bronopol following topical adn intravenous administration to rats. Toxicol Lett 6(2):101\u2013107. https:\/\/doi.org\/10.1016\/0378-4274(80)90175-7","journal-title":"Toxicol Lett"},{"key":"4077_CR4","volume-title":"An Introduction to Pharmacokinetics","author":"A BS Clark","year":"1986","unstructured":"ClarkD. A BS (1986) An Introduction to Pharmacokinetics, 2nd edn. Blackwell Scientific, Oxford","edition":"2"},{"key":"4077_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01582.x","author":"AC de Groot","year":"2009","unstructured":"de Groot AC, Flyvholm MA, Lensen G, Menne T, Coenraads PJ (2009) Formaldehyde-releasers: relationship to formaldehyde contact allergy. Contact allergy to formaldehyde and inventory of formaldehyde-releasers. Contact Dermatitis. https:\/\/doi.org\/10.1111\/j.1600-0536.2009.01582.x","journal-title":"Contact Dermatitis"},{"key":"4077_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1600-0536.2009.01615.x","volume":"62","author":"AC de Groot","year":"2010","unstructured":"de Groot AC, White IR, Flyvholm MA, Lensen G, Coenraads PJ (2010) Formaldehyde-releasers in cosmetics: relationship to formaldehyde contact allergy. Contact Dermatitis 62:18\u201331","journal-title":"Contact Dermatitis"},{"issue":"5","key":"4077_CR7","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00204-024-03704-7","volume":"98","author":"KE Ebert","year":"2024","unstructured":"Ebert KE, Griem P, Weiss T et al (2024) Toxicokinetics of homosalate in humans after dermal application: applicability of oral-route data for exposure assessment by human biomonitoring. Arch Toxicol 98(5):1383\u20131398. https:\/\/doi.org\/10.1007\/s00204-024-03704-7","journal-title":"Arch Toxicol"},{"key":"4077_CR9","unstructured":"ECHA (2017) Investigation Report Formaldehyde and Formaldehyde releasers. In. https:\/\/echa.europa.eu\/documents\/10162\/17233\/investigationreport_formaldehyde_workers-exposure_final_en.pdf\/ac457a0c-378d-4eae-c602-c7cd59abc4c5 Accessed 30 Apr 2025"},{"key":"4077_CR10","unstructured":"ECHA (2023a) Bronopol Registration dossier. In. https:\/\/echa.europa.eu\/de\/registration-dossier\/-\/registered-dossier\/11419\/6\/2\/3. Accessed 28 Feb 2025"},{"key":"4077_CR8","unstructured":"ECHA (2023b) CLH report Bronopol. In: REGULATION (EC) NO 1272\/2008 (CLP REGULATION), ANNEX VI, PART 2. https:\/\/echa.europa.eu\/documents\/10162\/92468463-a452-d047-a962-21bf5571a0b0. Accessed 30 Apr 2025"},{"key":"4077_CR11","unstructured":"ECHA (2025) Bronopol brief profile. In. https:\/\/echa.europa.eu\/de\/brief-profile\/-\/briefprofile\/100.000.131 Accessed 30 Apr 2025"},{"issue":"3","key":"4077_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00204-024-03938-5","volume":"99","author":"E Eckert","year":"2025","unstructured":"Eckert E, J\u00e4ger T, Leibold E, Bader M, G\u00f6en T, Hiller J (2025) Dermal penetration of 2-phenoxyethanol in humans: in vivo metabolism and toxicokinetics. Arch Toxicol 99(3):1095\u20131103. https:\/\/doi.org\/10.1007\/s00204-024-03938-5","journal-title":"Arch Toxicol"},{"issue":"9","key":"4077_CR13","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00204-019-02537-z","volume":"93","author":"J Hiller","year":"2019","unstructured":"Hiller J, Klotz K, Meyer S et al (2019) Toxicokinetics of urinary 2-ethylhexyl salicylate and its metabolite 2-ethyl-hydroxyhexyl salicylate in humans after simulating real-life dermal sunscreen exposure. Arch Toxicol 93(9):2565\u20132574. https:\/\/doi.org\/10.1007\/s00204-019-02537-z","journal-title":"Arch Toxicol"},{"issue":"2Pt A","key":"4077_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijheh.2016.10.012","volume":"220","author":"M Kolossa-Gehring","year":"2017","unstructured":"Kolossa-Gehring M, Fiddicke U, Leng G, Angerer J, Wolz B (2017) New human biomonitoring methods for chemicals of concern\u2014the German approach to enhance relevance. Int J Hyg Environ Health 220(2Pt A):103\u2013112. https:\/\/doi.org\/10.1016\/j.ijheh.2016.10.012","journal-title":"Int J Hyg Environ Health"},{"key":"4077_CR15","first-page":"27","volume":"33","author":"M Kujawa","year":"1987","unstructured":"Kujawa M, Macholz R, Seidler H et al (1987) Distribution and metabolism of 2-bromo-2-nitropropane-1,3-diol (bronopol). Z Gesamte Hyg 33:27\u201329","journal-title":"Z Gesamte Hyg"},{"issue":"4","key":"4077_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/jac\/dky520","volume":"74","author":"VE Lee","year":"2019","unstructured":"Lee VE, O\u2019Neill AJ (2019) Potential for repurposing the personal care product preservatives bronopol and bronidox as broad-spectrum antibiofilm agents for topical application. J Antimicrob Chemother 74(4):907\u2013911. https:\/\/doi.org\/10.1093\/jac\/dky520","journal-title":"J Antimicrob Chemother"},{"key":"4077_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2021.104888","volume":"122","author":"L Lopez-Sanchez","year":"2021","unstructured":"Lopez-Sanchez L, Miralles P, Salvador A, Merino-Sanjuan M, Merino V (2021) In vitro skin penetration of bronidox, bronopol and formaldehyde from cosmetics. Regul Toxicol Pharmacol 122:104888. https:\/\/doi.org\/10.1016\/j.yrtph.2021.104888","journal-title":"Regul Toxicol Pharmacol"},{"key":"4077_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0015-6264(76)80421-x","volume":"14","author":"DH Moore","year":"1976","unstructured":"Moore DH, Chasseaud LF, Lewis JD, Risdall PC, Crampton EL (1976) The metabolism of the antibacterial agent bronopol (2-bromo-2-nitropropane-1,3-diol) given orally to rats and dogs. Cosmet Toxicol 14:183\u2013187. https:\/\/doi.org\/10.1016\/s0015-6264(76)80421-x","journal-title":"Cosmet Toxicol"},{"key":"#cr-split#-4077_CR19.1","unstructured":"European Union (2009) Regulation"},{"key":"#cr-split#-4077_CR19.2","unstructured":"(EC) No. 1223\/2009 of the European Parliament and of the council. In. https:\/\/health.ec.europa.eu\/system\/files\/2016-11\/cosmetic_1223_2009_regulation_en_0.pdf Accessed 30 Apr 2025"},{"key":"4077_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.toxlet.2024.06.011","volume":"399","author":"I Sch\u00f6nrath","year":"2024","unstructured":"Sch\u00f6nrath I, Schmidtkunz C, Ebert KE et al (2024) Human urinary excretion kinetics of the antimycotic climbazole: Biomonitoring of two new metabolites after oral and dermal dosage. Toxicol Lett 399:25\u201333. https:\/\/doi.org\/10.1016\/j.toxlet.2024.06.011","journal-title":"Toxicol Lett"},{"key":"4077_CR21","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1128\/aac.32.11.1693","volume":"32","author":"JA Shepherd","year":"1988","unstructured":"Shepherd JA, Waigh RD, Gilbert P (1988) Antibacterial action of 2-bromo-2-nitropropane-1,3-diol (Bronopol). Antimicrob Agents Chemother 32:1693\u20131698. https:\/\/doi.org\/10.1128\/aac.32.11.1693","journal-title":"Antimicrob Agents Chemother"},{"key":"4077_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijheh.2020.113509","volume":"227","author":"M Stoeckelhuber","year":"2020","unstructured":"Stoeckelhuber M, Scherer M, Peschel O et al (2020) Human metabolism and urinary excretion kinetics of the UV filter Uvinul A plus(R) after a single oral or dermal dosage. Int J Hyg Environ Health 227:113509. https:\/\/doi.org\/10.1016\/j.ijheh.2020.113509","journal-title":"Int J Hyg Environ Health"},{"key":"4077_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)65610-8","author":"HH Taussky","year":"1954","unstructured":"Taussky HH, Kurzmann G (1954) A microcolorimetric determination of creatine in urine by the Jaffe reaction. J Biol Chem. https:\/\/doi.org\/10.1016\/S0021-9258(18)65610-8","journal-title":"J Biol Chem"},{"issue":"2","key":"4077_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaad.2013.09.047","volume":"70","author":"AB Wentworth","year":"2010","unstructured":"Wentworth AB, Yiannias JA, Keeling JH et al (2010) (2014) Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31. J Am Acad Dermatol 70(2):269-754 e4. https:\/\/doi.org\/10.1016\/j.jaad.2013.09.047","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04077-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04077-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04077-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:40:37Z","timestamp":1755697237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04077-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4077"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04077-1","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in compliance with the ethical principles outlined in the World Medical Association\u2019s Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of the Medical Faculty at Ruhr University Bochum, Germany (Registration No.: 19\u20136687\u2013BR). All participants received a written explanation of the study design and provided written informed consent prior to participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}